There is a great deal of confusion in aesthetics about what Profhilo is. Patients come to me having read about it online, having heard about it from friends, having seen it mentioned in glossy magazines — and almost all of them have a version of the same question: is it a filler?
The answer is no. But explaining why requires understanding what it actually does — which is something quite different from anything that came before it.
The Problem With How We Talk About Injectables
The aesthetic industry has a language problem. We use the word "filler" as a catch-all for anything that is injected into the face using hyaluronic acid, and that imprecision causes genuine confusion. It leads patients to assume that anything injectable will puff them up, add volume in ways they don't want, or give them the overdone look they associate with bad filler work.
Profhilo is injected. It contains hyaluronic acid. And it does absolutely none of those things.
To understand why, you need to understand what makes Profhilo structurally and functionally different from conventional dermal fillers — and that starts with the science.
What Profhilo Actually Is
Profhilo is a bioremodelling treatment. It was developed by IBSA, an Italian pharmaceutical company, and launched in the UK in 2015. It uses a patented technology called NAHYCO — Native Hybrid Cooperative Complex — which combines high molecular weight and low molecular weight hyaluronic acid in a single preparation using a unique thermal process rather than the chemical cross-linking used in conventional fillers.
This distinction matters enormously. Cross-linked hyaluronic acid — the kind used in fillers — is engineered to stay in one place. It is designed to resist the body's natural degradation processes, to maintain its structure, and to provide physical support or volume where it is placed. That is precisely what fillers are for.
Profhilo's hybrid hyaluronic acid is not cross-linked in the same way. When injected, it does not stay where it is placed. It disperses through the tissue — flowing through the dermis and integrating with the surrounding structures. This is not a flaw in the product. It is the mechanism. The slow, distributed release of hyaluronic acid across the tissue is what allows Profhilo to stimulate the biological processes that make it effective.
What It Actually Does
When Profhilo disperses through the dermis, it stimulates four types of skin cells: fibroblasts, keratinocytes, adipocytes, and macrophages. These cells respond to the presence of hyaluronic acid by increasing their production of collagen — both type I and type III — as well as elastin. These are the structural proteins responsible for skin firmness, elasticity, and that quality of bounce that characterises young skin.
The result is a genuine improvement in the architecture of the skin over time. Not a surface treatment. Not hydration alone. A remodelling of the dermal tissue itself — which is why the treatment is called bioremodelling rather than skin boosting or filling.
In practical terms, patients notice their skin becomes firmer, more elastic, and more luminous over the weeks following treatment. Lines soften not because anything has been injected into them, but because the tissue supporting the skin has been structurally improved. Laxity improves because the elastin network has been stimulated to rebuild. The overall quality and tone of the skin changes in a way that is difficult to achieve through any topical means.
The BAP Protocol
One of the distinctive features of Profhilo treatment is the injection protocol. Unlike conventional fillers, which are placed in multiple small deposits throughout the face, Profhilo is injected at five specific anatomical points on each side of the face — ten points in total. These are called the BAP points: Bio Aesthetic Points.
These points are not arbitrary. They are selected because they allow the product to flow efficiently through the tissue planes of the face, reaching the maximum area from the minimum number of injection sites. The result is effective coverage of the mid and lower face with minimal trauma to the skin.
The treatment takes around twenty minutes in clinical practice. Most patients find it comfortable; the product contains a small amount of lidocaine, and the injection sites are few. There is typically some minor swelling at the injection points for twenty-four to forty-eight hours, which resolves completely. Most patients are comfortable returning to normal activities immediately.
The Treatment Course
The standard Profhilo protocol consists of two treatment sessions, spaced four weeks apart. This is not arbitrary — the four-week interval is designed to allow the first treatment to begin stimulating collagen production before the second treatment amplifies that response.
Results develop progressively over the four to eight weeks following the second treatment, as the collagen and elastin stimulation matures. Patients typically notice the full effect at around the eight to twelve week mark — an improvement in skin quality, firmness, and radiance that colleagues and family often comment on before the patient fully registers the change themselves.
Maintenance treatments are typically recommended every six to twelve months, depending on the patient's age, skin condition, and individual response. In my experience, patients in their forties and fifties often benefit from two treatment sessions per year; younger patients maintaining good baseline skin quality may find once a year sufficient.
Who It Is For
Profhilo suits a wide range of patients, but it particularly excels in two groups. The first is patients in their late thirties to fifties who are noticing a loss of skin firmness and elasticity — the skin has become less bouncy, slightly crepey in texture, or has lost the quality of tension it once had. Profhilo addresses this directly by stimulating the structural proteins responsible for those qualities.
The second group is younger patients — often in their early to mid thirties — who want to invest in their skin's future. Used preventatively, Profhilo supports the skin's collagen infrastructure before significant depletion has occurred, maintaining quality rather than trying to restore it after the fact. This is, in my view, the most intelligent approach to aesthetics: treating the biology before the visible signs become established.
Profhilo is also an excellent choice for patients who are nervous about fillers or who have concerns about looking overdone. Because it adds no volume and makes no structural change to facial contour, the result is entirely natural. There is nothing to "see" — only an improvement in how the skin looks and feels that reads as health rather than treatment.
Profhilo and the Neck
One of the most valuable and underappreciated applications of Profhilo is the neck and décolletage. These areas are among the first to show the signs of skin ageing — thinning, crepiness, loss of elasticity — and among the most difficult to treat effectively with other modalities. Profhilo can be used in these areas with excellent results, stimulating collagen and elastin production in tissue that responds well to bioremodelling.
In my practice, I frequently recommend neck treatment alongside facial treatment for patients whose primary concern is overall skin quality rather than facial contouring. The combination produces a coherence of result — face and neck improving together — that facial treatment alone cannot achieve.
How It Compares to Other Treatments
Profhilo is often discussed alongside Skinvive and other skin quality treatments, and the comparison is worth addressing directly. Skinvive works primarily through hydration — delivering and maintaining moisture within the dermal tissue. The result is a surface-level luminosity and softness that is immediately visible and very consistent.
Profhilo works at a deeper level. Its primary mechanism is the stimulation of structural proteins — collagen and elastin — rather than hydration per se. The result develops more slowly and addresses different aspects of skin ageing: firmness, elasticity, and the quality of the tissue architecture itself.
Used together, the two treatments are highly complementary. Profhilo rebuilds the structure; Skinvive optimises the surface. In the right patient, the combination produces results that are genuinely impressive and entirely natural in appearance.
Profhilo is also frequently compared to collagen stimulators such as Sculptra and Juläine, which stimulate collagen through a different mechanism — the introduction of a biostimulatory substance that provokes a controlled tissue response. The distinction is in the mechanism and the timeline: biostimulators tend to produce more dramatic structural change over a longer period, while Profhilo produces a more subtle, quality-focused improvement over a shorter one. Neither is superior — they serve different purposes and suit different patients.
An Honest Assessment
Profhilo has been available in the UK for over a decade, and in that time it has accumulated a body of clinical evidence and a depth of patient experience that few aesthetic treatments can match. The results are consistent, reproducible, and genuinely meaningful for the right patient.
It will not restore lost volume. It will not redefine facial contours or lift significantly sagging tissue. What it will do — reliably, in my clinical experience — is improve the quality of the skin in a way that makes patients look like better versions of themselves. Healthier. More rested. More vital.
That is not a modest claim. For many patients, it is exactly what they are looking for.